March 23rd 2023
An analysis of perimenopausal women with rheumatoid arthritis indicated that patients receiving exogenous sex hormones more frequently achieved SDAI- and CDAI-defined remission.
Treatment Advancements to Overcome Barriers in the Management of Schizophrenia: Key Considerations for Pharmacists
1.5 Credit / Neurology, Psychiatry
View More
Effective Management of Moderate to Severe Pediatric Asthma: Applying Evidence-Based Case Reviews in Practice, featuring Patient Counseling Vignettes
1.5 Credits / Immunology, Respiratory
View More
Intravenous and Subcutaneous Immunoglobulin in the Management of Primary Immunodeficiency Disorders: Updates for Specialty Pharmacists
1.5 Credits / Immunology
View More
Comprehending Data From Integrated Continuous Glucose Monitoring Devices and Developing a Management Plan for Patients With Type 2 Diabetes (Pharmacy Technician Credit)
1.0 Credit / Endocrinology
View More
Comprehending Data From Integrated Continuous Glucose Monitoring Devices and Developing a Management Plan for Patients With Type 2 Diabetes (Pharmacist Credit)
1.0 Credit / Endocrinology
View More
Improving Clinical Outcomes for Anemia of Chronic Kidney Disease: A Focus on Novel Treatment Approaches (Pharmacy Technician Credit)
1.0 Credit / Hematology, Nephrology
View More
Improving Clinical Outcomes for Anemia of Chronic Kidney Disease: A Focus on Novel Treatment Approaches (Pharmacist Credit)
1.0 Credit / Hematology, Nephrology
View More
Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions and Mitigation of Health Equity Issues
1.0 Credit / Oncology, Women’s Health
View More
Failure to Reach LDL-C Target Increases Event Risk Nearly 50% in High-Risk Individuals
March 23rd 2023New research from the Family Heart Foundation indicates high-risk patients who fail to achieve LDL-C targets had a 49% greater rate of cardiovascular events than their counterparts who met LDL-C targets.
CRAVE Trials Offers Most Comprehensive Overview Yet of Impact of Coffee, Caffeine Intake
March 23rd 2023A 14-day randomized clinical trial assessing effects of caffeinated coffee consumption in a population of 100 adult patients, CRAVE offers what could be the most definitive insight yet into the effects of coffee consumption on overall health.
Statin Use for ASCVD Prevention Lower Among Black, Hispanic Individuals
March 22nd 2023An analysis of NHANES from 2013 - March 2020 suggest individuals with an indication for statin therapy for primary prevention based on 10-year risk saw low overall use across risk categories and race and ethnicity strata.
Updates in the Standards of Care in Diabetes in 2023 - Obesity and Weight Management
March 22nd 2023Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES, interview Scott Kahan, MD, MPH who serves on the committee that creates the ADA Standards of Care in Diabetes, to discuss the latest updates in weight management guidelines.
AHA/ACC Scientific Statement Reports Benefit of Supervised Exercise Training for HFpEF
March 22nd 2023Released on March 21, the new scientific statement suggests supervised exercise training is safe and may offer substantial improvement in exercise capacity and quality of life, even more than medications, for many patients with heart failure.
FDA Approves Evinacumab for HoFH in Children Aged 5-11 Years Old
March 22nd 2023The US FDA has approved an indication for evinacumab for use as an adjunct to other lipid-lowering therapies in children with homozygous familial hypercholesterolemia as young as 5 years old, which makes evinacumab the first ANGPTL3 inhibitor indicted for this patient population.
Adalimumab Biosimilar for Uveitis Similarly Efficacious to Bio-Originator
March 22nd 2023Data from the United Kingdom indicate Amgevita is safe and effective for non-infectious uveitis with non-inferiority to originator adalimumab, but a significant number of patients requested to switch back due to adverse events.
Improving Built Environments Could Help Address Adolescent Obesity
March 21st 2023Built environments, but not social and economic environments, were negatively associated with BMI and overweight or obesity status, with a stronger association among adolescents with longer exposure to their built environment.
Embracing Research and Finding Support to Manage Type 1 Diabetes
March 21st 2023In this MEDcast® episode, Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES, interview Sumita Singh to discuss her family’s journey as they navigated the challenges of their daughter’s T1D diagnosis and decided to enroll her in a clinical trial for a T1D treatment.